OncoSec Medical Incorporated
ONCSQ
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -6.86M | -8.06M | -8.22M | -6.25M | -9.91M |
| Total Depreciation and Amortization | 10.50K | 313.90K | 307.50K | 303.50K | 296.40K |
| Total Amortization of Deferred Charges | 9.50K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -531.40K | 1.09M | 487.70K | 351.90K | 836.70K |
| Change in Net Operating Assets | 761.30K | 532.30K | 504.90K | 251.20K | -1.24M |
| Cash from Operations | -6.61M | -6.13M | -6.92M | -5.34M | -10.01M |
| Capital Expenditure | -16.00K | -- | 0.00 | 0.00 | -244.90K |
| Sale of Property, Plant, and Equipment | 4.50K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.50K | -- | 0.00 | 0.00 | -244.90K |
| Total Debt Issued | 2.00M | -- | -- | -- | -- |
| Total Debt Repaid | -280.30K | -276.70K | -216.20K | -372.50K | -369.80K |
| Issuance of Common Stock | 3.50M | -- | 900.00 | 0.00 | 204.00K |
| Repurchase of Common Stock | -500.00 | -2.60K | -4.10K | -10.40K | -4.90K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -720.20K | -64.00K | -20.90K | 10.60K | -10.70K |
| Cash from Financing | 4.50M | -343.30K | -240.30K | -372.30K | -181.40K |
| Foreign Exchange rate Adjustments | 77.00K | -100.10K | -21.30K | -40.50K | -36.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.05M | -6.57M | -7.18M | -5.75M | -10.48M |